Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
Module home
Module introduction
Module information
About the authors
Pre-module test
Section 1: Brain structure and function
(1.1) Section 1: Brain structure and function
(1.2) Interactive exercise: neuroimaging techniques
(1.3) Brain volume
(1.4) Changes with abstinence
(1.5) Reflection
(1.6) Wernicke’s encephalopathy and Korsakoff’s syndrome
(1.7) Wernicke’s encephalopathy and Korsakoff’s syndrome
(1.8) Section 1: Recap
(1.9) Section 1: Summary
Section 2: The neurocircuitry of alcohol addiction
(2.1) Section 2: The neurocircuitry of alcohol addiction
(2.2) The neurocircuitry of alcohol addiction
(2.3) Early stages of addiction
(2.4) Addiction
(2.5) Brain regions important for addiction
(2.6) Functional MRI
(2.7) Interactive exercise: cue exposure studies
(2.8) Interactive exercise: cue exposure studies continued
(2.9) Effect of medication on cue exposure and craving
(2.10) Decision making
(2.11) Reward processing
(2.12) Section 2: Recap
(2.13) Section 2: Summary
Section 3: Pharmacology
(3.1) Section 3: Pharmacology
(3.2) How alchohol interacts with the brain
(3.3) How alchohol interacts with the brain
(3.4) Neuroimaging brain function
(3.5) Rewarding effects of alcohol: role of dopamine and opioid systems
(3.6) Interactive exercise: neuroimaging studies
(3.7) Rewarding effects of alcohol: the role of dopamine and modulators
(3.8) Regulation of the dopaminergic reward pathway: opioidergic neurotransmission
(3.9) Reflection
(3.10) Regulation of the dopaminergic reward pathway: opioidergic neurotransmission
(3.11) Section 3: Recap
(3.12) Section 3: Summary
Section 4: Pharmacology continued
(4.1) Section 4: Pharmacology continued
(4.2) What has neuroimaging told us about the opioid system?
(4.3) What have genetic studies told us about the opioid system?
(4.4) Serotonin (5HT)
(4.5) The effect of acute alcohol on serotonergic neurotransmission
(4.6) Clinical implications
(4.7) What have neuroimaging and genetic studies told us about the serotonergic system?
(4.8) Interactive exercise: GABA receptors
(4.9) GABA-A receptors
(4.10) What has neuroimaging told us about the GABA-benzodiazepine system?
(4.11) Pharmacological challenges
(4.12) What have genetic studies told us about the gabaergic system?
(4.13) NMDA receptors
(4.14) The effect of acute alcohol on glutamatergic neurotransmission
(4.15) The effect of chronic alcohol on glutamatergic neurotransmission
(4.16) Withdrawal
(4.17) Cannabinoid receptors
(4.18) The effect of acute alcohol on cannabinoid neurotransmission
(4.19) What has neuroimaging told us about the cannabinoid system?
(4.20) Section 4: Recap
(4.21) Section 4: Summary
Section 5: Pharmacotherapies for alcohol addiction
(5.1) Section 5: Pharmacotherapies for alcohol addiction
(5.2) Benzodiazepines
(5.3) Disulfiram
(5.4) Disulfiram
(5.5) Acamprosate
(5.6) Naltrexone and nalmefene
(5.7) Interactive exercise: other non-licensed medication in use and potential future therapies
(5.8) Interactive exercise: pharmacotherapies
(5.9) Summary table of pharmacotherapeutic effects
(5.10) Section 5: Recap
(5.11) Section 5: Summary
Module summary
Module summary I
Module summary II
Module test
Acknowledgements
Send feedback
Useful resources
Take-home notes
References
Further reading